Skip to main content

Decision on Bharat Biotech’s Covaxin Emergency Use Nod to be Made in October: WHO

New Delhi: A decision on Hyderabad-based pharma major Bharat Biotech’s submission seeking emergency use listing (EUL) of its COVID-19 vaccine — Covaxin will be made in October, said the World Health Organisation (WHO). The WHO’s statement came a day after reports of the EUL to be further delayed surfaced. At present, the status of assessment for Covaxin is ongoing . Bharat Biotech had submitted EOI (Expression of Interest) on April 19 for its vaccine.

The latest Status of COVID-19 vaccines within WHO EUL/PQ evaluation process’ guidance document dated September 29 on the WHO website said that the decision date for Bharat Biotech’s Covaxin is October 2021.

The WHO said it began rolling data of the vaccine on July 6. Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process. According to the WHO, submissions to WHO for prequalification or listing under the emergency use procedure are confidential.

If a product submitted for assessment is found to meet the criteria for listing, the WHO will publish the results widely. Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on those data meeting WHO criteria, according to the agency.

Bharat Biotech’s Covaxin and AstraZeneca and Oxford University’s Covishield are the two widely used vaccines in India. Bharat Biotech recently said it submitted all data pertaining to Covaxin to the WHO for EUL and is awaiting feedback from the global health watchdog.

On Tuesday, the pharma company said that it is diligently working with the WHO to obtain EUL at the earliest. Earlier this month, the company tweeted, “#COVAXIN clinical trial data was fully compiled & available in June 2021. All Data submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback.”

(With PTI inputs)



source https://www.india.com/news/india/decision-on-bharat-biotechs-covaxin-emergency-use-nod-to-be-made-in-october-who-4995592/

Comments

Post a Comment

Popular posts from this blog

UK Makes Face Mask Mandatory As Omicron Virus Spreads, 22 Test Positive

London: Face coverings are mandatory in shops and public transport from Tuesday as part of targeted measures” to slow the spread of the Omicron variant, 22 cases of which have now been detected in the UK after Scotland and England reported further infections. Individuals linked with all new cases, identified in the East Midlands, the East of England, London, and the North West, are all isolating and the UK Health Security Agency (UKHSA) said work is underway to identify any links to travel to southern Africa. “It is very likely that we will find more cases over the coming days as we are seeing in other countries globally and as we increase case detection through focused contact tracing, said Dr Jenny Harries, UKHSA Chief Executive. The enhanced measures, announced last week as a precaution while more information is gathered and assessed on the new variant’s transmissibility and any possible effect on current COVID-19 vaccines, also include compulsory PCR tests on arrival for all int...
Post a Comment
Read more

Weekly RT-PCR Mandatory For Unvaccinated Employees In Kerala. Details Here

Thiruvananthapuram : In an effort to make everyone get vaccinated, Kerala Chief Minister Pinarayi Vijayan on Tuesday said anyone not following COVID prevention measures, like vaccination, will not be provided free treatment. He also said that non-vaccinated teachers and employees who work from offices or interact with public will have to submit weekly results of RT-PCR tests. “No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RT-PCR tests, paid for by themselves, to ensure safety of all,” Vijayan said in a tweet. No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RTPCR tests, paid for by themselves, to ensure safety of all. — Pinarayi Vijayan (@vijayanpinarayi) November ...
Post a Comment
Read more